Cargando…
Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma
The expression of Sialyl-Tn (STn) in tumors is associated with metastatic disease, poor prognosis, and reduced overall survival. STn is expressed on ovarian cancer biomarkers including CA-125 (MUC16) and MUC1, and elevated serum levels of STn in ovarian cancer patients correlate with lower five-year...
Autores principales: | Eavarone, David A., Al-Alem, Linah, Lugovskoy, Alexey, Prendergast, Jillian M., Nazer, Rawan I., Stein, Jenna N., Dransfield, Daniel T., Behrens, Jeff, Rueda, Bo R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063429/ https://www.ncbi.nlm.nih.gov/pubmed/30052649 http://dx.doi.org/10.1371/journal.pone.0201314 |
Ejemplares similares
-
Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
por: Starbuck, Kristen, et al.
Publicado: (2018) -
Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity
por: Prendergast, Jillian M., et al.
Publicado: (2017) -
Challenges in Antibody Development against Tn and Sialyl-Tn Antigens
por: Loureiro, Liliana R., et al.
Publicado: (2015) -
The Role of Sialyl-Tn in Cancer
por: Munkley, Jennifer
Publicado: (2016) -
Sialyl Tn as a prognostic marker in epithelial ovarian cancer.
por: Kobayashi, H., et al.
Publicado: (1992)